Castle Biosciences, Inc.
US ˙ NasdaqGM ˙ US14843C1053

SecurityCSTL / Castle Biosciences, Inc.
InsiderEllen Goldberg
This page shows the track record and history of Goldberg Ellen insider trades in Castle Biosciences, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Ellen Goldberg in CSTL / Castle Biosciences, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2023-06-05 2,300 11.2300 2,300 11.2300 25,829 256 25.3000 32,361 125.29
2023-06-05 2,500 17.2700 2,500 17.2700 43,175

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CSTL / Castle Biosciences, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Ellen Goldberg in CSTL / Castle Biosciences, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

CSTL / Castle Biosciences, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-05-27 2026-05-22 4 Goldberg Ellen CSTL Common Stock M - Exercise D 13,667 40,921
2025-05-23 2025-05-21 4 Goldberg Ellen CSTL Common Stock M - Exercise D 8,673 27,254
2024-07-16 2024-07-14 4 Goldberg Ellen CSTL Common Stock M - Exercise D 440 18,581
2024-05-29 2024-05-25 4 Goldberg Ellen CSTL Common Stock M - Exercise D 8,636 18,141
2023-07-18 2023-07-14 4 Goldberg Ellen CSTL Common Stock M - Exercise D 440 9,505
2023-06-06 2023-06-02 4 Goldberg Ellen CSTL Common Stock M - Exercise D 3,825 4,265
2023-06-06 2023-06-05 4 Goldberg Ellen CSTL Common Stock P - Purchase D 17.2700 2,500 43 9,065
2023-06-06 2023-06-05 4 Goldberg Ellen CSTL Common Stock P - Purchase D 11.2300 2,300 26 6,565
2022-07-18 2022-07-14 4 Goldberg Ellen CSTL Common Stock M - Exercise D 440 440
2021-07-16 2021-07-14 4 Goldberg Ellen CSTL Restricted Stock Units A - Award D 1,320 1,320
2021-07-16 2021-07-14 4 Goldberg Ellen CSTL Stock option (right to buy) A - Award D 66.80 5,365 5,365
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)